JANUARY 2016 ARTICLE LIST >>
PharmaTutor (January- 2016)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 1)
Received On: 19/08/2015; Accepted On: 02/09/2015; Published On: 01/01/2016
AUTHORS:
Kavitha A*, Narendra Babu A, Sathish Kumar M, Veena Kiran S
Department of pharmacology
Chalapathi institute of pharmaceutical sciences, Guntur, AP, India
*andugulakavitha@gmail.com
ABSTRACT: Background: Hyperandrogenism and insulin resistance are the main manifestations of polycystic ovary syndrome (PCOS), which appears to be caused by exposure to androgenized models have developed and investigated to study the etiology of polycystic ovary syndrome.
Objective: To evaluate the modulatory effects of Commiphora wightii (C.wightii) resins in response to hyperandrogenism in polycystic ovary syndrome.
Method: The animals were divided 18 adult (5-6 months old) wistar rats in to 4 groups the PCOS model was induced by daily administration of dehydroepiandrosterone (DHEA) 6mg/Kg in sesame oil p.o., up to 15 days and the rescue groups were take daily with metformin and C.wightii resin ethanolic extract 100mg/ kg in addition to DHEA. Serum glucose levels measured and steroid hormone levels were measured by fully automated bidirectionally interfaced chemi luminescent immunoassay. Samples were stained with hematoxylin and eosin for histological morphology.
Results: The obtained results related to DHEA induced PCOS a significant (P<0.05) increase in hormone profile (estradiol, testosterone, progesterone, luteinizing hormone, follicle stimulated hormone) in PCOS rats in adult rats than the rescue groups. Furthermore glucose levels significantly (<0.05) elevated in PCOS rats compared with the other groups. The test treated ovaries had lower number of follicles compared to DHEA control group and similar to that of the control group than the standard.
Conclusion: Commiphora wightii resin has a potential role in reducing DHEA induced PCOS by reducing the morphological abnormalities of the ovarian follicles and normal hormone levels in adult rats.
How to cite this article: Kavitha A, Narendra BA, Sathish KM, Veena KS; Evaluation of effects of Commiphora Wightii in Dehydroepiandrosterone (DHEA) induced Polystic Ovary Syndrome (PCOS) in Rats; PharmaTutor; 2016; 4(1); 47-55
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R; Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord; 2002; 26(7); 883-896.
2. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P; Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first trimester spontaneous abortion: a pilot study; Fertil Steril; 2001; 75(1); 46-52.
3. Laura Borgelt; What Pharmacists Need to Know About Polycystic Ovary Syndrome (PCOS). 2011
4. Pratik Kumar Chatterjee , P.Prasanna Mithra , Rahul Pal , Poulomi Chatterjee , B.Unnikrishnan , N.A.Vinodini , Aparna Tripathi , V.B.Suman , Anish Singha, Sheila R. Pai; Epidemiological correlates among women with Polycystic ovary syndrome in South Indi;a int. J. Curr. Res. Aca. Rev; 2014; 2(9); 181-186.
5. Line Sveberg Røste, Erik Taubøll, Jouko I.T. Isojärvi , Aasmund Berner, Kjell Andersen Berg, Arto J. Pakarinen , Ilpo T. Huhtaniemi , Mikael Knip, Leif Gjerstad; Gonadal morphology and sex hormones in male and female Wistar rats after long-term lamotrigine treatment; Seizure 2003; 12(8); 621–627
6. Michael T. Sheehan, MD; Polycystic Ovarian Syndrome: Diagnosis and Management Clinical Medicine & Research Clin Med Res. 2004 Feb; 2(1): 13–27.
7. Bernier, Danielle, "Polycystic Ovary Syndrome: Pathogenesis, health consequences, and treatment of PCOS in relation to insulin resistance" (2012). Honors Theses. Paper 3.
8. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R; Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
9. merckmanuals.com/professional/gynecology-and-obstetrics/menstrual-abnormalities/premature-ovarianinsufficiency- or-failure
10. unboundmedicine.com/merckmanual/view/Merck-Manual/553926/all/Polycystic_Ovary_Syndrome_ PCOS
11. merckmanuals.com/home/women-s-health-issues/menstrual-disorders-and-abnormal-vaginal-bleeding
/polycystic-ovary-syndrome
12. Text book of applied therapeutics by Koda-Kimble 10th eddition
13. “The wealth of India”. First supplement series, raw materials, CSIR, 1956 (VI) L-M: 323-325.
14. C.S.Shah and J. S. Qadry. “Text book of Pharmacognosy”. B.S.Shah Prakasan, 1983; Ahmedabad. 1-15.
15. Buenz.et al. “Techniques: Bio prospecting historical herbal texts by hunting for new leads in old tomes”. Trends in Pharmacological Sciences: 2004; 25:494-498.
16. Anonymous. Zanzibar Traditional and Alternative Medicine Policy, 2008.
17. Weiss RF. Weiss’s herbal medicine. Thieme; 2001.
18. Benzie IF, Galor SW. Herbal Medicine: Biomolecular and Clinical Aspects. CRC Press; 2011. p. 7.
19. Muzler, J. Bohlmann. “The Role of Natural Products in Drug Discovery: Tools for drug discovery”. Ernst Schering Research Foundation, Springer – Verlag berlin, Heidelberg 2000 – New York: 5-6.
20. Acupuncture in Polycystic Ovary Syndrome: Current Experimental and Clinical Evidence E. Stener-Victorin, E. Jedel_ and L. Manneras Journal of Neuroendocrinology 20, 290–298.
21. Natural Remedies for Polycystic Ovarian Syndrome (PCOS): A Review Priyanka Kantivan Goswami, Dr. Anubha Khale, Sunita Ogale Int.J.Pharm.Phytopharmacol.Res. 2012, 1(6): 396-402.
.png)
